You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Ad5

Showing 26 - 50 of 9,742
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostate Cancer Trial in Detroit (Ad5-yCD/mutTKSR39rep-hIL12)

Active, not recruiting
  • Prostate Cancer
  • Ad5-yCD/mutTKSR39rep-hIL12
  • Detroit, Michigan
    Henry Ford Health System
Feb 17, 2022

Metastatic Pancreatic Cancer Trial in Detroit (Ad5-yCD/mutTKSR39rep-hIL12)

Completed
  • Metastatic Pancreatic Cancer
  • Ad5-yCD/mutTKSR39rep-hIL12
  • Detroit, Michigan
    Henry Ford Hospital
Feb 15, 2022

Prostatic Tumors, Prostatic Cancer Trial run by the NCI (ETBX-071; adenoviral PSA vaccine, ETBX-061; adenoviral MUC1 vaccine,

Completed
Has Results
  • Prostatic Neoplasms
  • Prostatic Cancer
  • ETBX-071; adenoviral PSA vaccine
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Apr 28, 2021

Platinum-refractory Ovarian Carcinoma, Platinum-resistant Ovarian Cancer Trial in Rochester, Helsinki (TILT-123, Pembrolizumab)

Recruiting
  • Platinum-refractory Ovarian Carcinoma
  • Platinum-resistant Ovarian Cancer
  • TILT-123
  • Pembrolizumab
  • Rochester, Minnesota
  • +1 more
Aug 12, 2022

COVID-19 Trial in United States (VXA-CoV2-1.1-S, Placebo Tablets)

Recruiting
  • COVID-19
  • Long Beach, California
  • +3 more
Sep 19, 2022

COVID-19 Trial in Wuhan (Ad5-nCoV)

Unknown status
  • COVID-19
  • Ad5-nCoV
  • Wuhan, Hubei, China
    Zhongnan Hospital
Dec 3, 2020

Neuroendocrine Tumors Trial in Uppsala (AdVince)

Recruiting
  • Neuroendocrine Tumors
  • Uppsala, Sweden
    Endocrine Oncology Clinic, Uppsala University Hospital
Nov 4, 2021

Healthy Trial in United States (Placebo, RSV preF Protein 50 mcg, RSV preF Protein 150 mcg)

Completed
  • Healthy
  • Placebo
  • +8 more
  • Huntsville, Alabama
  • +5 more
Aug 2, 2022

Tuberculosis Trial in Hamilton (Ad5Ag85A)

Completed
  • Tuberculosis
  • Ad5Ag85A
  • Hamilton, Ontario, Canada
    McMaster University Medical Centre
Oct 25, 2021

Lynch Syndrome Trial in Puerto Rico, United States (procedure, drug, other, biological)

Not yet recruiting
  • Lynch Syndrome
  • Biopsy
  • +5 more
  • Phoenix, Arizona
  • +13 more
Sep 16, 2022

Norovirus Infections Trial in Cypress (VXA-G1.1-NN)

Completed
  • Norovirus Infections
  • VXA-G1.1-NN
  • Cypress, California
    AltaSciences LA
Apr 27, 2022

Melanoma, Head and Neck Squamous Cell Carcinoma Trial in Helsinki (TILT-123, Avelumab)

Recruiting
  • Melanoma
  • Head and Neck Squamous Cell Carcinoma
  • Helsinki, Finland
    Docrates Cancer Center
Jul 12, 2022

Ebola Virus Disease Trial in Kambia (Ad26.ZEBOV booster vaccination, given at a dose of 5x10^10 vp, via IM injection)

Active, not recruiting
  • Ebola Virus Disease
  • Ad26.ZEBOV booster vaccination, given at a dose of 5x10^10 vp, via IM injection
  • Kambia, Sierra Leone
    EBOVAC Kambia 1 clinic
Feb 25, 2022

HIV Trial in United States (DNA Vaccine, DNA Vaccine , rAd35)

Completed
  • HIV Infections
  • DNA Vaccine
  • +5 more
  • Birmingham, Alabama
  • +9 more
Oct 13, 2021

Solid Tumor Trial in Helsinki (TILT-123)

Recruiting
  • Solid Tumor
  • TILT-123
  • Helsinki, Uusima, Finland
  • +1 more
Dec 17, 2021

Healthy Trial in Groningen (Ad26.COV2.S)

Completed
  • Healthy
  • Ad26.COV2.S
  • Groningen, Netherlands
    PRA Health Sciences
Dec 21, 2021

Diabetes, Type 1 Trial in Arnhem (Bi-hormonal closed-loop control, Open-loop control)

Not yet recruiting
  • Diabetes Mellitus, Type 1
  • Bi-hormonal closed-loop control
  • Open-loop control
  • Arnhem, Gelderland, Netherlands
    Rijnstate Ziekenhuis
Sep 13, 2022

COVID-19 Trial in Nanjing (Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) for Inhalation, Recombinant Novel

Recruiting
  • COVID-19
  • Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) for Inhalation
  • +3 more
  • Nanjing, Jiangsu, China
    Jiangsu Provincal Center for Disease Control and Prevention
Jul 27, 2021

Alzheimer's Disease Trial in Heidelberg, Shepparton, West Perth (SLS-005, Placebo)

Not yet recruiting
  • Alzheimer's Disease
  • Heidelberg, Victoria, Australia
  • +2 more
Dec 23, 2022

Colorectal Tumors, Colorectal Tumors, Colorectal Carcinoma Trial in Washington, Bethesda (Avelumab, Ad-CEA vaccine, Bevacizumab)

Terminated
Has Results
  • Colorectal Tumors
  • +4 more
  • Washington, District of Columbia
  • +1 more
Dec 10, 2021

Neurocognitive Disorders (MG)

Recruiting
  • Alzheimer Disease
  • +2 more
  • Identification of Graphic Markers
  • Montréal, Quebec, Canada
    CRIUGM
Sep 8, 2022

Dermatitis, Atopic Trial in Gwangju (FURESTEM-AD® inj. 5.0 X 10^7 cells/1.5 mL, Placebo)

Recruiting
  • Dermatitis, Atopic
  • FURESTEM-AD® inj. 5.0 X 10^7 cells/1.5 mL
  • Placebo
  • Gwangju, Jeollanam-do, Korea, Republic of
    Chosun University Hospital
Aug 5, 2021

Norovirus Infection Trial in Cleveland (VXA-G1.1-NN, VXA-G2.4-NS, Placebo Tablets)

Completed
  • Norovirus Infection
  • VXA-G1.1-NN
  • +2 more
  • Cleveland, Ohio
    Rapid Medical Research
Apr 23, 2021

Cocaine Dependence Trial in New York (dAd5GNE Vaccine, Placebo)

Recruiting
  • Cocaine Dependence
  • dAd5GNE Vaccine
  • Placebo
  • New York, New York
    WCMC Department of Genetic Medicine
Mar 29, 2022

Pancreas Cancer Trial in Seongnam (Theragene arm)

Recruiting
  • Pancreas Cancer
  • Theragene arm
  • Seongnam, Gyeonggi-do, Korea, Republic of
    Seoul National University Bundang Hospital
Mar 15, 2021